Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)

Clinical trial NCT04185883 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04185883
Sponsor: Amgen
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Kirsten Rat Sarcoma (KRAS) pG12C Mutation

Start date: 2019-12-17
Primary completion: 2026-12-17
Enrollment: 610

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.